SciELO - Scientific Electronic Library Online

 
 número12A metodologia de Coaching aplicada às Ciências da Nutrição: usos, potencialidades e controvérsias em PortugalRede de voluntários do projeto Nutrition UP 65: perspetivas do trabalho voluntário em intervenção comunitária e saúde pública índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Acta Portuguesa de Nutrição

versión On-line ISSN 2183-5985

Resumen

SILVA, Joana; PEREIRA, Paula; COUTO, Nuno  y  RAMALHO, Renata. Vitamin D and Cancer: from biological mechanisms to therapeutic utility. Acta Port Nutr [online]. 2018, n.12, pp.32-37. ISSN 2183-5985.  https://doi.org/10.21011/apn.2018.1206.

Vitamin D deficiency is a worldwide concern. The relationship between this deficiency and bone diseases is well established. However, recent studies have also linked this deficiency to increase risk of different types of cancer. Recently, in vitro and in vivo studies have shown that 1,25-dihydroxyvitamin D (1,25(OH)D) is able to produce anticancer effects through its binding to a specific intercellular receptor, the vitamin D receptor (VDR), which is active in both malignant and benignant cells in different organs and tissues, promoting gene transcription and protein synthesis. This discovery led to an increased clinical interest for the potential usage of vitamin D as a major help for the prevention and treatment against cancer. The authors present a review of the literature regarding the biological and biochemical mechanisms responsible for the anticancer effects of vitamin D; and explore in detail these effects towards the current evidence.

Palabras clave : 1,25(OH)D; Apoptosis; Cancer; Carcinogenesis; Vitamin D.

        · resumen en Portugués     · texto en Portugués     · Portugués ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons